Condition
PK in Healthy Volunteers
Total Trials
3
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
P 1 (3)
Trial Status
Completed3
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT07186283Phase 1CompletedPrimary
Pharmacokinetic Study of a Novel Cannabidiol (CBD) Formulation in Healthy Volunteers
NCT06698861Phase 1CompletedPrimary
A Phase I PK/PD Study of PEG-MetHuG-CSF (P2203) in Healthy Volunteers
NCT01340157Phase 1CompletedPrimary
Fexinidazole (1200mg) Bioavailability Under Different Food Intake Conditions
Showing all 3 trials